Cochrane Clinical Answers
Cochrane Clinical Answers (CCAs) provide a readable, digestible, clinically focused entry point to rigorous research from Cochrane systematic reviews. They are designed to be actionable and to inform decision making at the point of care and have been added to relevant sections of the main Best Practice text.
- How do calcium channel blockers compare with placebo in people with Raynaud's phenomenon?
- In people with primary Raynaud's phenomenon, how do calcium channel blockers affect outcomes?
Use of this content is subject to our disclaimer